“The goal of Lazarex Cancer Foundation is to let cancer patients know that there is hope, regardless of race, gender or ethnic background,”
Danville,Ca. (PRWEB) October 05, 2011
While cancer is colorblind, new studies show that minorities may not be screened or take part in possible life-saving clinical trials as often as their Caucasian counterparts. Dana Dornsife, founder of the Lazarex Cancer Foundation, is hoping to change that as R&B legend Lenny Williams joins forces with Lazarex Cancer Foundation to bring awareness to these groups.
“The goal of Lazarex Cancer Foundation is to let cancer patients know that there is hope, regardless of race, gender or ethnic background,” Dornsife said “The fact is that cancer research and clinical trials are only effective across the board if cancer patients of both sexes, all ages and ethnic groups are represented.”
Since October is Breast Cancer Awareness month, many studies have been released about the disparity in treatment of minority women for breast cancer. According to an article published in The Republic, a Columbus, Indiana newspaper:
- Asian and Hispanic women are less likely to get regular mammograms than white or black women. The reasons vary from lack of insurance, lack of awareness and cultural factors.
- Latino women are more likely than non-Hispanic whites to be diagnosed with breast cancer at a younger age and with worse tumors. However, they are not participating in clinical trials that could save their life.
- Japanese women are found to have as high a breast cancer rate as white women. Filipina women have the lowest five-year survival rate for breast cancer of any other ethnic group. The reasons are not known.
- African-American women have the highest rates of pre-menopausal breast cancer than other races and are more likely to die from the disease at any age.
- African-American women are more than twice as likely as white women to be diagnosed with early-onset, virulent tumors called triple-negatives. These tumors do not respond to current therapies for cancer treatment that block or eliminate those hormones.
The Centers for Disease Control and Prevention has recognized the health disparities in minorities. In a statement on its website, organization officials said, “Access to quality cancer care and clinical trials needs to be expanded to ensure that minority groups are provided the same care and access to state-of-the-art technology that patients in major care centers receive.”
In African American men, prostate cancer strikes them earlier than it does men in other races and they are twice as likely to die from the disease. Even with an increased awareness about the importance of screening, many African American men are not taking part.
R&B legend Lenny Williams joins forces with Lazarex Cancer Foundation to bring awareness to these groups and to encourage them to engage in more clinical trials that can prolong their life and lead to new discoveries in cancer research. Williams and Dornsife are speaking to churches,organizations, civic groups and the media about this important initiative that could save lives and help advance cancer research as well as encourage cancer screenings for African Americans. For more information contact Karen Ambrogi at 877-866-9523 or visit http://www.lazarex.org.